Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV-MPL vs Engerix-B in Healthy Adults
NCT00697216Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 1997
- Primary completion
- Mar 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentrations at Month 7. Started Mar 1997; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697216.